Obesity is a major factor in metabolic disorders and premature deaths in developing countries. The risk of type 2 diabetes mellitus (DM) increases many folds in association with obesity. Cystatin C is an early marker for nephropathy, and it can also predict peripheral neuropathy, retinopathy and arterial sclerosis apart from renal function. Cystatin C is also associated with Cardiovascular events and limb ischemia Associated complications deteriorate the quality of life of patients and increase the morbidity rate.
(2023). Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity. Egyptian Society of Diabetes and Lipidology Journal, 3(2), -. doi: 10.21608/esdlj.2023.456214
MLA
. "Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity", Egyptian Society of Diabetes and Lipidology Journal, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456214
HARVARD
(2023). 'Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity', Egyptian Society of Diabetes and Lipidology Journal, 3(2), pp. -. doi: 10.21608/esdlj.2023.456214
VANCOUVER
Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456214
)
